Could a Micro-Dose of bone protein make dental implants safer and stronger?

NCT ID NCT07696299

First seen Jul 10, 2026 · Last updated Jul 10, 2026

Summary

This study compares two doses of a bone-growth protein (rhBMP-2) against a placebo to see if a lower dose can improve dental implant stability while reducing side effects. Sixty adults needing a single implant in the lower jaw will be randomly assigned to receive a standard dose, a micro-dose, or a saline placebo during implant placement. Researchers will measure implant stability, bone loss, and complications like swelling and pain over 12 weeks. The goal is to find out if a smaller dose can work just as well with fewer problems.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
recombinant human bone morphogenetic protein-2 (rhBMP-2)
What this could lead to
If successful, this could lead to a safer, more affordable way to improve dental implant success by using a lower dose of a bone-growth protein.
What could go wrong
This is a small, early-phase trial with only 60 participants, so results may not apply to everyone. The lower dose might not work as well as the standard dose, and there is a risk of side effects like swelling or pain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DENTAL IMPLANT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Tooth Loss

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Dr. Mahdi Dental Clinic

    Baghdad, Baghdad Governorate, 10001, Iraq

    Contact Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.